Innovative Molecules raises €20 million Series A equity financing round
Proceeds dedicated to advance Herpes simplex treatment IM-250 to Phase II IM-250 demonstrates unprecedented impact o…
Proceeds dedicated to advance Herpes simplex treatment IM-250 to Phase II IM-250 demonstrates unprecedented impact o…
According to the latest report by Renub Research, titled "China Molecular Diagnostics Market & Volume Forecast, by Appli…
Existing investors in biotech innovator Abviris Deutschland GmbH are injecting almost two million Euros to speed up expa…
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the G…
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic gr…
In the corona crisis, packaging is playing an important role in helping to supply people with food, medicines and PPE. A…
ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Pr…
ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Pr…
ISA Pharmaceuticals B.V., a clinical-stage company dedicated to the development of rationally designed immunotherapeutic…
ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Pr…